Actress Sarah Jessica Parker is ending her relationship with pharmaceutical giant Mylan and speaking out against how the company jacked the price of EpiPens to more than $600 each.
She announced that she has cut ties due to the price hikes in a Thursday statement on Instagram. Parker had been involved with an unbranded Mylan ad campaign about anaphylaxis, as her son has a severe peanut allergy.
“I’m left disappointed, saddened and deeply concerned by Mylan’s actions,” Parker wrote in the statement. “I hope they…will take swift action to lower the cost to be more affordable for whom it is a life-saving necessity.”
On Thursday, Mylan had announced that it would expand its patient-assistance program to reduce costs for people who couldn’t afford EpiPens. The move came after Democratic presidential nominee Hillary Clinton spoke against the price hike and its stock plummeted Wednesday.
More Must-Reads from TIME
- Caitlin Clark Is TIME's 2024 Athlete of the Year
- Where Trump 2.0 Will Differ From 1.0
- Is Intermittent Fasting Good or Bad for You?
- The 100 Must-Read Books of 2024
- Column: If Optimism Feels Ridiculous Now, Try Hope
- The Future of Climate Action Is Trade Policy
- FX’s Say Nothing Is the Must-Watch Political Thriller of 2024
- Merle Bombardieri Is Helping People Make the Baby Decision
Write to Julia Zorthian at julia.zorthian@time.com